ORVS in RheumAI

ORVS means Optimistic Response Verification System. Erick Zamora published the reference document as a preprint on March 28, 2026, with DOI 10.55277/researchhub.qq2fdvw9.[1]

In RheumAI, ORVS is a post-generation review. It evaluates the model’s response. It does not directly validate whether the input clinical note contains every field BIOBADAMEX requires.

Preprint and current code

They are not the same contract. The preprint describes a four-dimension rubric, up to three cycles, and human escalation.[1] Normal chat uses the legacy six-dimension version, attempts one regeneration, and has no ORVS human-escalation queue. V2 modes are experimental extensions: Quick uses four dimensions and Deep uses eight. Quick’s weights resemble the preprint, but current TMP and RSC meanings changed to temporal reasoning and therapeutic completeness.

Conceptual flow

1. RheumAI generates a response from the question and retrieved evidence.
2. An evaluator model scores several dimensions.
3. A low score can trigger regeneration or a targeted addendum.
4. A separate control compares cited PubMed IDs against IDs retrieved in that turn.
5. The system returns the result or applies a fallback when time runs out.

Implementations in the repository

Normal chat

Normal chat calls v1 verification for clinical requests and non-trivial questions. It scores six dimensions from 0–100:

• citation accuracy;
• clinical accuracy;
• specificity;
• evidence alignment;
• response completeness;
• absence of contradictions.

The threshold is 70. A failed score causes one regeneration attempt with evaluator flags. The regenerated response is not sent through ORVS again in that normal path.

Explicit comparison modes

A client that supplies pipelineMode can select quick-orvs or full-orvs:

Mode	Dimensions	Purpose
Quick ORVS v2	clinical accuracy, safety, temporal reasoning, therapeutic completeness	Fast review
Deep ORVS v2	the four above plus completeness, citations, clarity, and bias	Wider review

V2 computes a 0–100 composite and can regenerate or append targeted corrections up to two times.

Citation controls

The chat flow adds deterministic PubMed rules:

• Retrieved PubMed evidence without an inline PMID can trigger regeneration.
• Only PMIDs retrieved during the current turn are permitted.
• A remaining disallowed identifier is replaced with [unverified PMID].

This is more deterministic than asking a model whether a citation looks plausible.

Important limits

• ORVS evaluates generated output. It does not prove that a recommendation is clinically correct.
• The evaluator is also a model and can fail.
• The preprint describes a proposal and retrospective experiments using constructed scenarios.[1] It does not demonstrate clinical outcomes, regulatory approval, or safety for autonomous use.
• Current parse or API errors can return a result marked passed with error flags. This is fail-open behavior, not successful validation.
• ORVS_ENABLED=false disables verification.
• The stateless study route does not explicitly run final ORVS after REPLY.
• ORVS “completeness” asks whether the response covers the question. It is not chart or registry completeness.

Relationship to note completeness

BiobadamexAI needs two separate evaluations:

1. Note completeness: applicable registry fields are present, missing, unknown, or not applicable.
2. Response quality: RheumAI’s explanation is accurate, safe, evidence-aware, clear, and useful.

ORVS can support the second. The first requires an explicit clinical schema and field-level provenance. See Clinical notes and completeness.

Code evidence

• ORVS implementation
• Evaluation prompts
• Chat use and PMID controls
• Comparison modes

Sources

[1] https://www.researchhub.com/post/32066/optimistic-response-verification-system — Optimistic Response Verification System > “Optimistic Response Verification System” > “March 28, 2026”